Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS/PI3K/Akt/mTOR axis

References

• Van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–10. doi:10.1002/ejhf.483.
   PubMed Web of Science ®Google Scholar
• Rajadurai J, Tse HF, Wang CH, Yang NI, Zhou J, Sim D. Understanding the epidemiology of heart failure to improve management practices: an Asia-Pacific perspective. J Card Fail. 2017;23(4):327–39. doi:10.1016/j.cardfail.2017.01.004.
   PubMed Web of Science ®Google Scholar
• Lee TM, Lin SZ, Chang NC. Antiarrhythmic effect of lithium in rats after myocardial infarction by activation of Nrf2/HO-1 signaling. Free Radic Biol Med. 2014;77:71–81. doi:10.1016/j.freeradbiomed.2014.08.022.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li K, Yang J, Feng YX, Huang W, Wu XY, Zhang Y. Effect and mechanism of emodin on carotid stenosis after balloon injury in rats. J Thir Mil Med Univer. 2017;1:48–53.
   Google Scholar
• Carver W, Fix E, Fix C, Fan D, Chakrabarti M, Azhar M. Effects of emodin, a plant-derived anthraquinone, on TGF-β1-induced cardiac fibroblast activation and function. J Cell Physiol. 2021;236(11):7440–49. doi:10.1002/jcp.30416.
   PubMed Web of Science ®Google Scholar
• Zhao XA, Chen G, Liu Y, Wu H, Chen J, Xiong Y, Tian C, Jia B, Wang G, Xia J, et al. Emodin alleviates liver fibrosis of mice by reducing infiltration of Gr1hi monocytes. Evid Based Complement Alternat Med. 2018;2018:5738101. doi:10.1155/2018/5738101.
   PubMed Web of Science ®Google Scholar
• Tian SL, Yang Y, Liu XL, Xu QB. Emodin attenuates bleomycin-induced pulmonary fibrosis via anti-inflammatory and anti-oxidative activities in rats. Med Sci Monit. 2018;24:1–10. doi:10.12659/MSM.905496.
   PubMed Web of Science ®Google Scholar
• Yang F, Deng L, Li J, Chen M, Liu Y, Hu Y, Zhong W. Emodin retarded renal fibrosis through regulating HGF and TGFβ-smad signaling pathway. Drug Des Devel Ther. 2020;14:3567–75. doi:10.2147/DDDT.S245847.
   PubMed Web of Science ®Google Scholar
• Dou F, Liu Y, Liu L, Wang J, Sun T, Mu F, Guo Q, Guo C, Jia N, Liu W, et al. Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway in vivo and in vitro. Rejuvenation Res. 2019;3(3):218–29. doi:10.1089/rej.2018.2104.
   Google Scholar
• Yang W, Wu Z, Yang K, Han Y, Chen Y, Zhao W, Huang F, Jin Y, Jin W. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway. Am J Physiol Heart Circ Physiol. 2019;1(1):h61–69. doi:10.1152/ajpheart.00487.2018.
   Google Scholar
• Xian M, Cai J, Zheng K, Liu Q, Liu Y, Lin H, Liang S, Wang S. Aloe-emodin prevents nerve injury and neuroinflammation caused by ischemic stroke via the PI3K/AKT/mTOR and NF-κB pathway. Food Funct. 2021;17(17):8056–67. doi:10.1039/D1FO01144H.
   Google Scholar
• Zhang Y, Zhang YL, Li W, Wang P, Gu R, Feng YX, Wei SJ, Peng K, Zhang YR, Su LN, et al. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury. J Am Heart Assoc. 2017;6(10):e002641. doi:10.1161/JAHA.117.006593.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Wen XD, Guo X, Huang SQ, Wang TT, Zhou PT, Li W, Zhou LF, Hu YH. Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD6α/JNK/c‑Jun signalling pathway. Oncol Rep. 2021;45(6):95. doi:10.3892/or.2021.8046.
   Web of Science ®Google Scholar
• Xiao D, Zhang Y, Wang R, Fu Y, Zhou T, Diao H, Wang Z, Lin Y, Li Z, Wen L, et al. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharm Sin B. 2014;9(4):724–33. doi:10.1016/j.apsb.2019.04.003.
   Google Scholar
• González A, Schelbert EB, Díez J, Butler J. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71(15):1696–706. doi:10.1016/j.jacc.2018.02.021.
   PubMed Web of Science ®Google Scholar
• Erasmus M, Samodien E, Lecour S, Cour M, Lorenzo O, Dludla P, Pheiffer C, Johnson R. Linking LOXL2 to cardiac interstitial fibrosis. Int J Mol Sci. 2020;21(16):5913. doi:10.3390/ijms21165913.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang J, Xue M, Li X, Han F, Liu X, Xu L, Lu Y, Cheng Y, Li T, et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol. 2019;18(1):15. doi:10.1186/s12933-019-0816-2.
   PubMedGoogle Scholar
• Wu H, Li GN, Xie J, Li R, Chen QH, Chen JZ, Wei ZH, Kang LN, Xu B. Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc Disord. 2016;16(1):5. doi:10.1186/s12872-015-0169-z.
   PubMedGoogle Scholar
• Meng Z, Li HY, Si CY, Liu YZ, Teng S. Asiatic acid inhibits cardiac fibrosis throughNrf2/HO-1 and TGF-β1/Smads signaling pathways in spontaneous hypertension rats. Int Immunopharmacol. 2019;74:105712. doi:10.1016/j.intimp.2019.105712.
   PubMed Web of Science ®Google Scholar
• Kang LL, Zhang DM, Jiao RQ, Pan SM, Zhao XJ, Zheng YJ, Chen TY, Kong LD. Pterostilbene attenuates fructose-induced myocardial fibrosis by inhibiting ROS-Driven Pitx2c/miR-15b pathway. Oxid Med Cell Longev. 2019;2019:1243215. doi:10.1155/2019/1243215.
   PubMed Web of Science ®Google Scholar
• Zhu W, Wu RD, Lv YG, Liu YM, Huang H, Xu JQ. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation. Biomed Pharmacother. 2020;121:109368. doi:10.1016/j.biopha.2019.109368.
   PubMed Web of Science ®Google Scholar
• Li K, Zhai M, Jiang L, Song F, Zhang B, Li J, Li H, Li B, Xia L, Xu L, et al. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway. Oxid Med Cell Longev. 2019;2019:6746907. doi:10.1155/2019/6746907.
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu H, Yang D, He F, Yuan Y, Guo J, Hu J, Yu J, Yan X, Wang S, et al. Aloe-emodin attenuates myocardial infarction and apoptosis via up-regulating miR-133 expression. Pharmacol Res. 2019;146:104315. doi:10.1016/j.phrs.2019.104315.
   PubMed Web of Science ®Google Scholar
• Lee EH, Baek SY, Park JY, Kim YW. Emodin in rheum undulatum inhibits oxidative stress in the liver via AMPK with Hippo/Yap signalling pathway. Pharm Biol. 2020;1(1):333–41. doi:10.1080/13880209.2020.1750658.
   Google Scholar
• Danpinid A, Luo J, Vappou J, Terdtoon P, Konofagou EE. In vivo characterization of the aortic wall stress–strain relationship. Ultrasonics. 2010;7(7):654–65. doi:10.1016/j.ultras.2010.01.003.
   Google Scholar
• Li ML, Li RN, Ma YM, Jiang B, Chen YJ, Hu WX, Qv CL, Zhang YJ, Song YY, Wang Y. MiRNA-1297 inhibits myocardial fibrosis by targeting ULK1. Eur Rev Med Pharmacol Sci. 2020;4:2070–76.
   Google Scholar
• Evans LW, Bender A, Burnett L, Godoy L, Shen Y, Staten D, Zhou T, Angermann JE, Ferguson BS. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy. J Nutr Biochem. 2020;79:108339. doi:10.1016/j.jnutbio.2019.108339.
   PubMed Web of Science ®Google Scholar
• Chen Q, Pang L, Huang S, Lei W, Huang D. Effects of emodin and irbesartan on ventricular fibrosis in Goldblatt hypertensive rats. Pharmazie. 2014;5:374–78.
   Google Scholar
• Zheng XY, Yang SM, Zhang R, Wang SM, Li GB, Zhou SW. Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes. Drug Des Devel Ther 2019, 13: 3171–3180. 10.2147/DDDT.S204958.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhao X, Yan X, Li W, Liu Y, Wang J, Wang J, Yang Y, Hao Y, Liang Z, et al. Aloe-emodin ameliorated MI-induced cardiac remodeling in mice via inhibiting TGF-β/SMAD signaling via up-regulating SMAD7. Phytomedicine. 2023;114:154793. doi:10.1016/j.phymed.2023.154793.
   PubMed Web of Science ®Google Scholar
• Dong X, Fu J, Yin X, Cao S, Li X, Lin L, Huyiligeqi NJ. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;8(8):1207–18. doi:10.1002/ptr.5631.
   Google Scholar